The Trump administration’s effort to impose new requirements on Novavax’s COVID-19 vaccine — the nation’s only traditional ...

Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...

The AACR meeting was full of promising data on the vaccine against cervical cancer, a lung cancer drug and the next ...

A new study seems to confirm that a single dose of the vaccine used to prevent HPV infection is just as effective as two — ...

When it comes to getting the most out of a vaccine, arm consistency can make a difference. Some studies suggest that getting ...

Sydney scientists have revealed why receiving a booster vaccine in the same arm as your first dose can generate a more ...

Merck stock could take another hit Thursday after the company reported another quarter of light sales for its HPV vaccine, ...

The company’s stock fell as much as 2.8% after markets opened in New York Thursday. For the first quarter, Merck’s results ...

Merck & Co. said it expects to lose $200 million to already-announced tariffs in 2025 amid an escalating trade war between ...

On an earnings call in February, he answered question after question about plunging demand for his company’s vaccine against ...

The findings from Fred Hutch Cancer Center suggest next step of exploring whether one dose of the vaccine is enough.

we’re delighted to see progress in innovative treatments and very much welcome the expansion of this vaccine trial. “The use of vaccines to treat melanoma is an exciting development and we ...